Long-acting contraceptives and cancer risk A new study has found long-acting contraceptives seem to be as safe as the pill when it comes to cancer risk.
Dire 60-day script predictions fail to materialise As well as saving patients money, more pharmacies have opened than have closed since the policy first came into effect in September 2023.
‘Promising’ new statistical tool predicts dementia onset Early research shows the model can predict onset more accurately than similar tools, with hopes it will give patients more time to make decisions.
Contraceptive pill Slinda recommended for PBS listing In its decision, the PBAC highlighted the importance of patients having access to a range of contraceptive options without cost barriers.
PBS co-payment freeze rolls out In 2025, the maximum patient cost for all PBS medicines will remain the same as in 2024 instead of increasing with indexation.
‘Breakthrough’ blood test for endometriosis: Study A new and non-invasive way to test early for the often-debilitating condition has been developed by Australian researchers.
TGA renews calls to limit new HRT patch prescriptions The reoccurring shortages are now expected to last until the end of 2025, raising concerns from GPs about how to support their patients long-term.
Federal Government backs ADHD prescribing consistency In response to last year’s Senate Inquiry, it also supports-in-principle calls to review relevant MBS items and pathways to GP assessments.
Endometriosis drug Visanne added to PBS Doctors have described dienogest as ‘miraculous’, with its listing expected to positively impact up to 500,000 patients.
Initiative urges women to communicate menopause symptoms SPONSORED: Menopause conversations coming out of the shadows, but many are unsure how to have the right discussion with their GPs.